Torley Helen's Form 4 filing
Halozyme Therapeutics, Inc. (HALO) · filed Oct 3, 2025
- Accession no.
- 0001528185-25-000004
- Filed
- Oct 3, 2025
- Trade date
- Oct 1-3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.31M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Torley HelenCIK 0001528185 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $8.11 | +$162,200 | 753,719 | Direct | |
| Oct 1, 2025 | Common Stock | SSaleDisposed | −11,705 | $75.11 | −$879,162.55 | 742,014 | Direct | |
| Oct 1, 2025 | Common Stock | SSaleDisposed | −8,295 | $75.69 | −$627,848.55 | 733,719 | Direct | |
| Oct 2, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $8.11 | +$162,200 | 753,719 | Direct | |
| Oct 2, 2025 | Common Stock | SSaleDisposed | −6,600 | $70.51 | −$465,366 | 747,119 | Direct | |
| Oct 2, 2025 | Common Stock | SSaleDisposed | −10,200 | $71.28 | −$727,056 | 736,919 | Direct | |
| Oct 2, 2025 | Common Stock | SSaleDisposed | −2,400 | $72.07 | −$172,968 | 734,519 | Direct | |
| Oct 2, 2025 | Common Stock | SSaleDisposed | −700 | $73.24 | −$51,268 | 733,819 | Direct | |
| Oct 2, 2025 | Common Stock | SSaleDisposed | −100 | $74.67 | −$7,467 | 733,719 | Direct | |
| Oct 3, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $8.11 | +$162,200 | 753,719 | Direct | |
| Oct 3, 2025 | Common Stock | SSaleDisposed | −14,235 | $68.47 | −$974,670.45 | 739,484 | Direct | |
| Oct 3, 2025 | Common Stock | SSaleDisposed | −2,334 | $69.83 | −$162,983.22 | 737,150 | Direct | |
| Oct 3, 2025 | Common Stock | SSaleDisposed | −2,707 | $70.58 | −$191,060.06 | 734,443 | Direct | |
| Oct 3, 2025 | Common Stock | SSaleDisposed | −724 | $71.67 | −$51,889.08 | 733,719 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $8.11 | −$162,200 | 116,569 | Direct | |
| Oct 2, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $8.11 | −$162,200 | 96,569 | Direct | |
| Oct 3, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $8.11 | −$162,200 | 76,569 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.